SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006597
Filing Date
2020-05-14
Accepted
2020-05-14 16:01:41
Documents
65
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atre-20200331x10q.htm 10-Q 2155826
2 EX-31.1 atre-20200331ex311f5d768.htm EX-31.1 10658
3 EX-31.2 atre-20200331ex3126f7f15.htm EX-31.2 10581
4 EX-32.1 atre-20200331ex321b43beb.htm EX-32.1 10774
  Complete submission text file 0001558370-20-006597.txt   6519232

Data Files

Seq Description Document Type Size
5 EX-101.INS atre-20200331.xml EX-101.INS 1310502
6 EX-101.SCH atre-20200331.xsd EX-101.SCH 35297
7 EX-101.CAL atre-20200331_cal.xml EX-101.CAL 54555
8 EX-101.DEF atre-20200331_def.xml EX-101.DEF 162341
9 EX-101.LAB atre-20200331_lab.xml EX-101.LAB 325684
10 EX-101.PRE atre-20200331_pre.xml EX-101.PRE 292013
Mailing Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 20877626
SIC: 2834 Pharmaceutical Preparations